Why does null hypothesis testing matter for organoid drug response analysis?

Null hypothesis testing enables objective comparison of gene expression and cellular composition between treated and control organoids, supporting rigorous target validation and mechanistic de-risking in early discovery.

How does independent variable isolation fit the organoid drug treatment workflow?

Strict control of drug concentration, vehicle, and treatment timing ensures that observed transcriptomic changes are attributable to the drug, increasing confidence in mechanistic interpretation and downstream decision-making.

What do quantitative dependent variable measurements enable in this protocol?

Quantitative metrics such as organoid area, diameter, and cell viability provide standardized outputs for comparing treatment effects, enabling reproducible assessment of compound efficacy and cellular response.

Why are replication requirements critical for cross-functional collaboration in organoid studies?

Consistent replication of organoid culture, drug treatment, and single-cell processing ensures data reliability, facilitating cross-team integration and portfolio-level analytics in translational research.

What statistical analysis capabilities are required before implementing single-cell transcriptomic profiling?

Capabilities must include clustering, differential gene expression, and pathway enrichment analyses to interpret single-cell data, supporting robust evaluation of drug-induced changes and target engagement.

יצירה וניתוח טרנסקריפטומי חד-תאי של אורגנואידים של קרצינומה כבדית לאחר טיפול תרופתי

412 צפיות

08:18 דק'

26 במאי 2026

10.3791/70511-v

26 במאי 2026

412 צפיות

Dan He^*¹ , Zhong Liang^*¹^,²^,³ , Cheng-Yang Zhang^*¹^,²^,³ , Jie-Shen Xian^*⁴ , Yuan-Xiang Yang⁵ , Yuan-Feng Gong³ , Hui Tang³ , Guang-Ding Zhou¹^,²^,³ , Chen-Yu Jiang¹^,²^,³ , Le Xing¹^,²^,³ , Dong-Mei Li¹^,²^,³ , Ying-Chen Hou¹^,²^,³ , Chen Yue¹^,²^,³ , Wei Cheng¹^,² , Yun-Qiang Tang³ , Ming Liu¹^,²^,³ , Xiao-Feng Zhang¹^,²^,³^,⁶

¹School of Basic Medical Science, Guangzhou Medical University, ²Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University, ³Affiliated Cancer Hospital and Institute, Guangzhou Medical University, ⁴The First Clinical School of Guangzhou Medical University, Guangzhou Medical University, ⁵Department of Obstetrics, Guangzhou Eighth People's Hospital, Guangzhou Medical University, ⁶Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University

^* These authors contributed equally

פרוטוקול זה מתאר שיטה יעילה ליצירת אורגנואידים של קרצינומה כבדית, יישום טיפול תרופתי וביצוע ריצוף RNA חד-תאי לפני ואחרי הטיפול לאפיון שינויים שעתוקיים הקשורים לטיפול.